Find information on thousands of medical conditions and prescription drugs.

Elitek

Rasburicase is a recombinant urate oxidase enzyme. It is used for the prevention and treatment of tumor lysis syndrome in patients receiving chemotherapy for hematologic cancers such as leukemias and lymphomas.

It catalyses the conversion of uric acid to allantoin. Allantoin is much more soluble than uric acid, so renal excretion is more effective.

Home

E-Base

Edecrin

Effexor

Elavil

Elidel

Eligard

Elitek

Elmiron

Elspar

Emtriva

Endep

Enulose

Epi-pen

Epinephrine

Epirubicin

Epitol

Epivir

Epogen

Eryc

Eryped

Esgic

Esmolol

Estrace

Estring

Estrone

Evista

Exelon

Exemestane

Hexal Australia

Read more at Wikipedia.org

• [List your site here Free!]



	2002 biotech drug launches The FDA has approved 20 new biotechnology-based drugs and vaccines as well as 15 new indications for previously approved biotech products in 2002. According to the Biotechnology Industry Organiza From Drug Cost Management Report, 2/1/03

	New drug protects kids from excess uric acid DRUG NEWS ELITEK The rapid rise of plasma uric acid levels is a main feature of tumor lysis syndrome, which occurs soon after treatment of hematologic ... From Nursing, 12/1/02

	Current Competition in China's Mobile Phone Design Industry Home Market is Tough and Price Wars Have Become Universal DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c24133) has announced the addition of China Mobile Phone Design Industry ... From Business Wire, 9/12/05

	Research and Markets: Market Leaders in Oncology 2004 - Roche and Genentech Continue to Blaze a Trail DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c12125) has announced the addition of Market Leaders in Oncology 2004 - Roche and Genentech Continue to Blaze a Tr From Business Wire, 1/24/05

Home

Contact

Resources

Exchange Links

ebay